当前位置：首页 SCI期刊 SCIE期刊医学中科院4区 JCRQ2 期刊介绍(非官网)

Pharmaceutical Development And TechnologySCIE

国际简称：PHARM DEV TECHNOL 参考译名：药物开发与技术

中科院分区
4区
CiteScore分区
Q2
JCR分区
Q2

基本信息：: ISSN：1083-7450; E-ISSN：1097-9867; 是否OA：未开放; 是否预警：否; TOP期刊：否

出版信息：: 出版地区：UNITED STATES; 出版商：Informa Healthcare; 出版语言：English; 出版周期：Bimonthly; 出版年份：1996; 研究方向：医学-药学

评价信息：: 影响因子：2.6; H-index：50; CiteScore指数：5.9; SJR指数：0.476; SNIP指数：0.609

发文数据：: Gold OA文章占比：5.68%; 研究类文章占比：84.52%; 年发文量：84; 自引率：0.0294...; 开源占比：0.024; 出版撤稿占比：0; 出版国人文章占比：0.11; OA被引用占比：0.0074...

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Pharmaceutical Development And Technology期刊介绍

Pharmaceutical Development & Technology publishes research on the design, development, manufacture, and evaluation of conventional and novel drug delivery systems, emphasizing practical solutions and applications to theoretical and research-based problems. The journal aims to publish significant, innovative and original research to advance the frontiers of pharmaceutical development and technology.

Through original articles, reviews (where prior discussion with the EIC is encouraged), short reports, book reviews and technical notes, Pharmaceutical Development & Technology covers aspects such as:

-Preformulation and pharmaceutical formulation studies

-Pharmaceutical materials selection and characterization

-Pharmaceutical process development, engineering, scale-up and industrialisation, and process validation

-QbD in the form a risk assessment and DoE driven approaches

-Design of dosage forms and drug delivery systems

-Emerging pharmaceutical formulation and drug delivery technologies with a focus on personalised therapies

-Drug delivery systems research and quality improvement

-Pharmaceutical regulatory affairs

This journal will not consider for publication manuscripts focusing purely on clinical evaluations, botanicals, or animal models.

期刊简介Pharmaceutical Development And Technology期刊介绍

《Pharmaceutical Development And Technology》自1996出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间：约1.0个月
医学
PHARMACOLOGY & PHARMACY
SCIE
中科院4区
非预警

Cite Score数据（2024年最新版）Pharmaceutical Development And Technology Cite Score数据

CiteScore：5.9
SJR：0.476
SNIP：0.609

学科类别	分区	排名	百分位
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Pharmaceutical Science	Q2	59 / 183	68%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Pharmaceutical Development And Technology 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：否

大类学科	分区	小类学科	分区
医学	4区	PHARMACOLOGY & PHARMACY 药学	4区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Pharmaceutical Development And Technology JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：PHARMACOLOGY & PHARMACY	SCIE	Q2	173 / 354	51.3%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：PHARMACOLOGY & PHARMACY	SCIE	Q2	122 / 354	65.68%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计

国家/地区数量
CHINA MAINLAND63
USA49
Egypt39
Iran39
Brazil26
England26
Turkey26
India23
GERMANY (FED REP GER)20
New Zealand19

本刊中国学者近年发表论文

1、Bilayer nanofibrous wound dressing prepared by electrospinning containing gallic acid and quercetin with improved biocompatibility, antibacterial, and antioxidant effects
Author: Lv, Yuanju; Wu, Wenli; Liu, Zemei; Zheng, Guangyan; Wang, Lihong; Che, Xin

Journal: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY. 2023; Vol. 28, Issue 1, pp. 18-29. DOI: 10.1080/10837450.2022.2160734
2、Microemulsion-thermosensitive gel composites as in situ-forming drug reservoir for periodontitis tissue repair through alveolar bone and collagen regeneration strategy
Author: Ding, Yang; Wang, Yuxiao; Li, Jiaxin; Tang, Maomao; Chen, Hairong; Wang, Guichun; Guo, Jian; Gui, Shuangying

Journal: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY. 2023; Vol. 28, Issue 1, pp. 30-39. DOI: 10.1080/10837450.2022.2161574
3、Bacterial outer membrane vesicles-cloaked modified zein nanoparticles for oral delivery of paclitaxel
Author: Wang, Zeyu; Chu, Yuqi; Tao, Xu; Li, Jianchao; Wang, Lihong; Sang, Yuli; Lu, Xiuli; Chen, Lijiang

Journal: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1080/10837450.2023.2204163
4、Fabrication and in vitro characterization of zinc oxide nanoparticles and hyaluronic acid-containing carboxymethylcellulose gel for wound healing application
Author: Paramadini, Adanti Wido; Chinavinijkul, Panarin; Meemai, Aniroot; Thongkam, Peerawat; Apasuthirat, Adisorn; Nasongkla, Norased

Journal: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY. 2023; Vol. 28, Issue 1, pp. 95-108. DOI: 10.1080/10837450.2022.2164304
5、Surface Modification of lactose carrier particles using a fluid bed coater to improve fine particle fraction for dry powder inhalers
Author: Gong, Qin Qin; Tay, Justin Yong Soon; Veronica, Natalia; Xu, Jian; Heng, Paul Wan Sia; Zhang, Yong Ping; Liew, Celine Valeria

Journal: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY. 2023; Vol. 28, Issue 2, pp. 164-175. DOI: 10.1080/10837450.2023.2171434
6、Preparation and cytotoxicity evaluation of folic acid-modified YF8-OA self-assembled lipid prodrug nanoparticles
Author: Li, Fu; Yang, Fangfang; Guan, Chenxi; Wei, Pengcheng; He, Dongqiong; Li, Qingwen; Wang, Lisheng; Yuan, Mingqing

Journal: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1080/10837450.2023.2206487
7、Application of a novel multicomponent nanoemulsion to tumor therapy Based on the theory of unification of drugs and excipients
Author: Li, Quandong; Chen, Xinru; Lin, Wen; Guo, Xiaofeng; Ma, Yan

Journal: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1080/10837450.2023.2196330
8、Mucoadhesive buccal film containing ornidazole and dexamethasone for oral ulcers: in vitro and in vivo studies.
Author: Zhang C¹, Liu Y¹, Li W¹, Gao P², Xiang D¹, Ren X¹, Liu D¹.

Journal: Pharm Dev Technol. 2019 Jan;24(1):118-126. doi: 10.1080/10837450.2018.1428814. Epub 2018 Jan 25.